Consolidated Statements of Stockholders' Equity - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2017	$ 25,000	$ 71,272,000	$ (53,531,000)	$ 17,766,000
Balance, shares at Dec. 31, 2017	25,213,805
Fair Value Allocation of Warrants		193,000		193,000
Common stock issued for legal fees		200,000		200,000
Common stock issued for legal fees, shares	123,456
Issuance of Common Stock	$ 2,000	2,812,000		2,814,000
Issuance of Common Stock, shares	2,139,235
Common stock issued for directors fees		305,000		305,000
Common stock issued for directors fees, shares	253,071
Common stock issued for convertible notes	$ 1,000	1,026,000		1,027,000
Common stock issued for convertible notes, shares	663,286
Stock Compensation Expense		293,000		293,000
Net Loss			(10,992,000)	(10,992,000)
Balance at Dec. 31, 2018	$ 28,000	76,101,000	(64,523,000)	11,606,000
Balance, shares at Dec. 31, 2018	28,392,853
Common stock issued for legal fees		126,000		126,000
Common stock issued for legal fees, shares	50,000
Issuance of Common Stock		186,000		186,000
Issuance of Common Stock, shares	182,778
Issuance of Common Stock for Note Conversion	$ 1,000	638,000		639,000
Issuance of Common Stock for Note Conversion, shares	424,805
Common stock issued for directors fees		244,000		244,000
Common stock issued for directors fees, shares	257,602
Share Issuance Costs		(113,000)		(113,000)
Stock Compensation Expense		378,000		378,000
Other Adjustments - Shares Issued
Other Adjustments - Shares Issued, shares	170,300
Other Adjustments - FV Allocation		(126,000)		(126,000)
Other Adjustments - Rounding			(2,000)	(2,000)
Net Loss			(2,732,000)	(2,732,000)
Balance at Dec. 31, 2019	$ 29,000	$ 77,434,000	$ (67,257,000)	$ 10,206,000
Balance, shares at Dec. 31, 2019	29,478,338